Volatility & Risk
PetVivo has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.
Profitability
This table compares PetVivo and Retractable Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PetVivo | -902.82% | -4,813.07% | -281.78% |
| Retractable Technologies | -41.11% | -17.15% | -9.33% |
Institutional and Insider Ownership
24.5% of PetVivo shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Comparatively, 57.1% of Retractable Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PetVivo | $1.05 million | 27.96 | -$10.95 million | ($0.40) | -2.50 |
| Retractable Technologies | $38.16 million | 0.66 | -$7.01 million | ($0.29) | -2.88 |
Retractable Technologies has higher revenue and earnings than PetVivo. Retractable Technologies is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.
Summary
Retractable Technologies beats PetVivo on 9 of the 11 factors compared between the two stocks.
About PetVivo
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
About Retractable Technologies
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
